Rabeprazole
- 1 January 1999
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 58 (4) , 725-742
- https://doi.org/10.2165/00003495-199958040-00014
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Review article: rabeprazole’s profile in patients with gastrointestinal diseasesAlimentary Pharmacology & Therapeutics, 1999
- Antacids have no influence on the pharmacokinetics of rabeprazole, a new proton pump inhibitor, in healthy volunteers.1999
- Double‐blind, placebo‐controlled comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of erosive or ulcerative gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1999
- Comparison of rabeprazole 20 mg vs. omeprazole 20 mg in the treatment of active gastric ulcer—a European multicentre studyAlimentary Pharmacology & Therapeutics, 1998
- An ascending single‐dose safety and tolerance study of an oral formulation of rabeprazole (E3810)Alimentary Pharmacology & Therapeutics, 1998
- Effects of oral rabeprazole on oesophageal and gastric pH in patients with gastro‐oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 1997
- LansoprazoleDrugs, 1997
- Determination of a new H+—K+ ATPase inhibitor (E3810) and its four metabolites in human plasma by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1994
- OmeprazoleDrugs, 1994
- The potency of substituted benzimidazoles such as E3810, omeprazole, RO 18-5364 to inhibit gastric H+,K+-ATPase is correlated with the rate of acid-activation of the inhibitorBiochemical Pharmacology, 1990